NEA Management Company as of March 31, 2017
Portfolio Holdings for NEA Management Company
NEA Management Company holds 38 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 55.0 | $1.6B | 10M | 153.87 | |
Ardelyx (ARDX) | 6.2 | $178M | 14M | 12.65 | |
Achaogen | 4.6 | $132M | 5.2M | 25.23 | |
Dermira | 4.2 | $120M | 3.5M | 34.11 | |
Epizyme | 3.7 | $107M | 6.3M | 17.15 | |
Ra Pharmaceuticals | 2.6 | $74M | 3.5M | 21.29 | |
Crispr Therapeutics (CRSP) | 2.4 | $70M | 3.2M | 21.77 | |
Adaptimmune Therapeutics (ADAP) | 2.3 | $66M | 12M | 5.51 | |
Groupon | 2.1 | $59M | 15M | 3.93 | |
Senseonics Hldgs (SENS) | 1.6 | $47M | 26M | 1.79 | |
Glycomimetics (GLYC) | 1.6 | $47M | 8.6M | 5.43 | |
Care | 1.4 | $41M | 3.3M | 12.51 | |
Cascadian Therapeutics | 1.3 | $38M | 9.1M | 4.14 | |
Aurinia Pharmaceuticals (AUPH) | 1.2 | $35M | 4.8M | 7.34 | |
Obseva Sa | 1.2 | $35M | 3.3M | 10.41 | |
Lexicon Pharmaceuticals (LXRX) | 1.2 | $34M | 2.4M | 14.34 | |
Nevro (NVRO) | 1.2 | $34M | 360k | 93.70 | |
Proteostasis Therapeutics In | 1.0 | $28M | 3.6M | 7.82 | |
Strongbridge Bioph shs usd | 0.7 | $20M | 4.1M | 4.75 | |
Endologix | 0.6 | $18M | 2.5M | 7.24 | |
Aerohive Networks | 0.6 | $18M | 4.3M | 4.21 | |
Trevena | 0.5 | $14M | 3.8M | 3.67 | |
Rigel Pharmaceuticals | 0.4 | $10M | 3.2M | 3.20 | |
Tracon Pharmaceuticals | 0.4 | $10M | 2.8M | 3.75 | |
AVEO Pharmaceuticals | 0.3 | $9.7M | 16M | 0.59 | |
Affimed Therapeutics B V | 0.3 | $8.9M | 3.9M | 2.30 | |
Mirna Therapeutics | 0.2 | $6.5M | 3.0M | 2.19 | |
Dasan Zhone Solutions | 0.2 | $6.0M | 956k | 6.25 | |
Sunesis Pharmaceuticals Inc Ne | 0.2 | $5.3M | 1.3M | 4.10 | |
Champions Oncology (CSBR) | 0.2 | $5.0M | 1.6M | 3.17 | |
Akari Therapeutics | 0.2 | $5.0M | 452k | 11.07 | |
Arca Biopharma | 0.1 | $3.7M | 1.5M | 2.55 | |
Roka Bioscience | 0.1 | $3.2M | 894k | 3.56 | |
ArQule | 0.1 | $2.7M | 2.5M | 1.06 | |
Paratek Pharmaceuticals | 0.0 | $1.3M | 66k | 19.25 | |
Orexigen Therapeutics | 0.0 | $1.3M | 371k | 3.44 | |
Cerecor | 0.0 | $405k | 595k | 0.68 | |
Catalyst Biosciences | 0.0 | $410k | 44k | 9.43 |